Wei Hu

7.3k total citations · 1 hit paper
116 papers, 5.0k citations indexed

About

Wei Hu is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Wei Hu has authored 116 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 28 papers in Reproductive Medicine and 22 papers in Oncology. Recurrent topics in Wei Hu's work include Ovarian cancer diagnosis and treatment (27 papers), Circadian rhythm and melatonin (9 papers) and FOXO transcription factor regulation (8 papers). Wei Hu is often cited by papers focused on Ovarian cancer diagnosis and treatment (27 papers), Circadian rhythm and melatonin (9 papers) and FOXO transcription factor regulation (8 papers). Wei Hu collaborates with scholars based in China, United States and Macao. Wei Hu's co-authors include Yang Yang, Shuai Jiang, Zhiqiang Ma, Tian Li, Chongxi Fan, Shouyin Di, Zhi Yang, Anil K. Sood, Jianjun Lv and Xiaolong Yan and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Wei Hu

112 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Signaling pathways in rheumatoid arthritis: implications for targeted therapy

2023 244 citations Wei Hu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Hu China	45	2.3k	875	672	647	539	116	5.0k
Gerasimos P. Sykiotis Switzerland	32	2.7k 1.2×	1.6k 1.8×	304 0.5×	795 1.2×	496 0.9×	104	6.0k
Min Zhang China	44	3.1k 1.4×	420 0.5×	592 0.9×	637 1.0×	497 0.9×	249	5.8k
Masataka Majima Japan	46	2.0k 0.9×	1.0k 1.2×	494 0.7×	881 1.4×	345 0.6×	255	6.8k
Faith B. Davis United States	52	3.5k 1.6×	1.0k 1.2×	641 1.0×	541 0.8×	414 0.8×	140	7.8k
Yunfeng Zhou China	31	1.5k 0.7×	545 0.6×	564 0.8×	281 0.4×	396 0.7×	165	3.6k
Barbara Mroczko Poland	40	1.5k 0.7×	1.5k 1.8×	959 1.4×	849 1.3×	374 0.7×	286	5.2k
Yoshinobu Hirose Japan	41	2.1k 0.9×	1.2k 1.4×	749 1.1×	297 0.5×	444 0.8×	276	5.8k
Adam Krętowski Poland	37	1.7k 0.8×	283 0.3×	513 0.8×	645 1.0×	739 1.4×	336	5.5k
Hong‐Yo Kang Taiwan	41	2.6k 1.2×	698 0.8×	783 1.2×	329 0.5×	187 0.3×	121	5.1k
Junping Zhang China	45	3.0k 1.3×	504 0.6×	1.2k 1.8×	679 1.0×	845 1.6×	229	5.5k

Countries citing papers authored by Wei Hu

Since Specialization

Citations

This map shows the geographic impact of Wei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Hu more than expected).

Fields of papers citing papers by Wei Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Hu. The network helps show where Wei Hu may publish in the future.

Co-authorship network of co-authors of Wei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Hu. A scholar is included among the top collaborators of Wei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Hu. Wei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Wei, Yang Xie, Tingting Wang, et al.. (2024). Costimulatory Molecule CD226 Regulates Atopic Dermatitis in a Mouse Model. Journal of Investigative Dermatology. 144(8). 1743–1753.e4. 2 indexed citations

Li, Wei, Haihong Chen, Hongliang Chen, et al.. (2023). Andrias davidianus bone peptides alleviates hyperuricemia-induced kidney damage in vitro and in vivo. Food Science and Human Wellness. 13(4). 1886–1905. 6 indexed citations

Liu, Yang, Qincao Chen, Dechun Liu, et al.. (2022). Multi-omics and enzyme activity analysis of flavour substances formation: Major metabolic pathways alteration during Congou black tea processing. Food Chemistry. 403. 134263–134263. 78 indexed citations

Hu, Wei, Jiangang Xie, Xuexue Xu, et al.. (2021). CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype. Journal of Translational Medicine. 19(1). 477–477. 19 indexed citations

Corvigno, Sara, Jared K. Burks, Wei Hu, et al.. (2021). Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status. Journal of Cancer Research and Clinical Oncology. 147(12). 3545–3555. 6 indexed citations

Ma, Shaolin, Sunila Pradeep, Alejandro Villar‐Prados, et al.. (2019). GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. Molecular Cancer Therapeutics. 18(5). 969–979. 13 indexed citations

Zhang, Jinxue, Ran Zhuang, Xuexin Zhang, et al.. (2019). CD226 is involved in megakaryocyte activation and early-stage differentiation. Molecular Immunology. 107. 123–131. 7 indexed citations

Yi, Xin, Jinxue Zhang, Ran Zhuang, et al.. (2018). Silencing LAIR-1 in human THP-1 macrophage increases foam cell formation by modulating PPARγ and M2 polarization. Cytokine. 111. 194–205. 21 indexed citations

Hu, Wei, Jiangang Xie, Yuan Zhang, et al.. (2018). TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 3085–3098. 29 indexed citations

10.

Huang, Yan, Lenard M. Lichtenberger, Morgan Taylor, et al.. (2016). Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer. Molecular Cancer Therapeutics. 15(12). 2894–2904. 42 indexed citations

11.

Huang, Jie, Wei Hu, Limin Hu, et al.. (2016). Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth. Molecular Cancer Therapeutics. 15(6). 1344–1352. 41 indexed citations

12.

Yang, Yang, Chongxi Fan, Shouyin Di, et al.. (2016). Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress. Cellular Physiology and Biochemistry. 38(3). 1226–1244. 52 indexed citations

13.

Feng, Jianyu, Yang Yang, Yajun Zhou, et al.. (2016). Bakuchiol attenuates myocardial ischemia reperfusion injury by maintaining mitochondrial function: the role of silent information regulator 1. APOPTOSIS. 21(5). 532–545. 49 indexed citations

14.

Thanapprapasr, Duangmani, Rebecca A. Previs, Wei Hu, et al.. (2015). PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer. Molecular Cancer Therapeutics. 14(6). 1466–1475. 15 indexed citations

15.

Kang, Yu, Archana S. Nagaraja, Guillermo N. Armaiz-Peña, et al.. (2015). Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer. Clinical Cancer Research. 22(7). 1713–1724. 77 indexed citations

16.

Wen, Yunfei, Whitney A. Spannuth Graybill, Rebecca A. Previs, et al.. (2014). Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer. Clinical Cancer Research. 21(2). 448–459. 53 indexed citations

17.

Bottsford-Miller, Justin, Hyun Jin Choi, Heather J. Dalton, et al.. (2014). Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer. Clinical Cancer Research. 21(3). 602–610. 73 indexed citations

18.

Tucker, Susan L., Kshipra M. Gharpure, Shelley M. Herbrich, et al.. (2014). Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 20(12). 3280–3288. 68 indexed citations

19.

Ge, Yan, Liyuan Zhang, Jiangping Wu, et al.. (2008). In pregnant mice, the infection of Toxoplasma gondii causes the decrease of CD4⁺CD25⁺‐regulatory T cells. Parasite Immunology. 30(9). 471–481. 39 indexed citations

20.

Fu, Siqing, J. J. Kavanagh, Wei Hu, & Robert C. Bast. (2006). Clinical application of oxaliplatin in epithelial ovarian cancer. International Journal of Gynecological Cancer. 16(5). 1717–1732. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact